SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/11/24 LifeMD, Inc. 10-K 12/31/23 79:20M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 2.20M 2: EX-10.110 Material Contract HTML 24K 3: EX-21.1 Subsidiaries List HTML 21K 4: EX-23.1 Consent of Expert or Counsel HTML 21K 9: EX-97.DESCRIBTION Clawback Policy re: Recovery of Erroneously HTML 22K Awarded Compensation 5: EX-31.1 Certification -- §302 - SOA'02 HTML 28K 6: EX-31.2 Certification -- §302 - SOA'02 HTML 28K 7: EX-32.1 Certification -- §906 - SOA'02 HTML 23K 8: EX-32.2 Certification -- §906 - SOA'02 HTML 23K 15: R1 Cover HTML 97K 16: R2 Consolidated Balance Sheets HTML 160K 17: R3 Consolidated Balance Sheets (Parenthetical) HTML 61K 18: R4 Consolidated Statements of Operations HTML 136K 19: R5 Consolidated Statements of Changes in HTML 120K Stockholders' Equity (Deficit) 20: R6 Consolidated Statements of Cash Flows HTML 162K 21: R7 Nature of the Organization and Business HTML 74K 22: R8 Summary of Significant Accounting Policies HTML 140K 23: R9 Acquisitions HTML 51K 24: R10 Goodwill and Intangible Assets HTML 44K 25: R11 Accrued Expenses HTML 31K 26: R12 Notes Payable HTML 45K 27: R13 Long-Term Debt HTML 39K 28: R14 Stockholders? Equity HTML 419K 29: R15 Leases HTML 40K 30: R16 Commitments and Contingencies HTML 64K 31: R17 Related Party Transactions HTML 42K 32: R18 Income Taxes HTML 61K 33: R19 Segment Data HTML 40K 34: R20 Subsequent Events HTML 27K 35: R21 Summary of Significant Accounting Policies HTML 197K (Policies) 36: R22 Summary of Significant Accounting Policies HTML 61K (Tables) 37: R23 Acquisitions (Tables) HTML 30K 38: R24 Goodwill and Intangible Assets (Tables) HTML 38K 39: R25 Accrued Expenses (Tables) HTML 31K 40: R26 Stockholders? Equity (Tables) HTML 288K 41: R27 Leases (Tables) HTML 38K 42: R28 Income Taxes (Tables) HTML 60K 43: R29 Segment Data (Tables) HTML 36K 44: R30 Nature of the Organization and Business (Details HTML 230K Narrative) 45: R31 Schedule of Disaggregated Revenue (Details) HTML 33K 46: R32 Schedule of Contract With Customer Liability HTML 31K (Details) 47: R33 Summary of Inventory (Details) HTML 30K 48: R34 Schedule of Potentially Dilutive Securities HTML 32K (Details) 49: R35 Summary of Significant Accounting Policies HTML 146K (Details Narrative) 50: R36 Schedule of Fair Value of Assets and Liabilities HTML 42K (Details) 51: R37 Acquisitions (Details Narrative) HTML 109K 52: R38 Schedule of Goodwill and Intangible Assets HTML 45K (Details) 53: R39 Goodwill and Intangible Assets (Details Narrative) HTML 47K 54: R40 Schedule of Accrued Expenses (Details) HTML 39K 55: R41 Notes Payable (Details Narrative) HTML 80K 56: R42 Long-Term Debt (Details Narrative) HTML 98K 57: R43 Schedule of Option Activity (Details) HTML 144K 58: R44 Schedule of Restricted Stock Unit Activity HTML 45K (Details) 59: R45 Schedule of Warrant and Restricted Stock HTML 41K Outstanding and Exercisable (Details) 60: R46 Schedule of Warrant Outstanding and Exercisable HTML 73K (Details) 61: R47 Stockholders? Equity (Details Narrative) HTML 767K 62: R48 Schedule of Operating Right of Use of Assets HTML 27K (Details) 63: R49 Schedule of Maturity of Operating Lease HTML 29K Liabilities (Details) 64: R50 Schedule of Other Information Related to Operating HTML 28K Lease Liabilities (Details) 65: R51 Leases (Details Narrative) HTML 31K 66: R52 Commitments and Contingencies (Details Narrative) HTML 123K 67: R53 Related Party Transactions (Details Narrative) HTML 61K 68: R54 Schedule of Income Tax Provision Charges (Details) HTML 47K 69: R55 Schedule of Provision Differs From the Amount of HTML 46K Income Tax (Details) 70: R56 Schedule of Net Deferred Tax Liabilities (Details) HTML 41K 71: R57 Income Taxes (Details Narrative) HTML 25K 72: R58 Schedule of Relevant Segment Data (Details) HTML 49K 73: R59 Segment Data (Details Narrative) HTML 23K 74: R60 Subsequent Events (Details Narrative) HTML 36K 76: XML IDEA XML File -- Filing Summary XML 131K 79: XML XBRL Instance -- form10-k_htm XML 2.48M 75: EXCEL IDEA Workbook of Financial Report Info XLSX 231K 11: EX-101.CAL XBRL Calculations -- lfmd-20231231_cal XML 222K 12: EX-101.DEF XBRL Definitions -- lfmd-20231231_def XML 1.04M 13: EX-101.LAB XBRL Labels -- lfmd-20231231_lab XML 1.64M 14: EX-101.PRE XBRL Presentations -- lfmd-20231231_pre XML 1.25M 10: EX-101.SCH XBRL Schema -- lfmd-20231231 XSD 219K 77: JSON XBRL Instance as JSON Data -- MetaLinks 553± 804K 78: ZIP XBRL Zipped Folder -- 0001493152-24-009581-xbrl Zip 479K
Exhibit 32.2
LIFEMD, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report on Form 10-K of LifeMD, Inc. (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
Date: | March 11, 2024 | |
By: | /s/ Marc Benathen | |
Name: | Marc Benathen | |
Title: | Chief Financial Officer (Principal Financial Officer) |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/11/24 | None on these Dates | ||
For Period end: | 12/31/23 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/24 LifeMD, Inc. S-8 3/15/24 8:4.8M M2 Compliance LLC/FA |